Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
PhaseBio Pharmaceuticals Inc (PHASQ)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
25 Oct 2022
NEW ENTERPRISE ASSOCIATES 13 LP
10% Owner
PhaseBio Pharmaceuticals Inc
(PHAS)
4,857,525
-26%
1,784,109
$0.15
$262,264.03
SELL
20 May 2022
Burkhardt Glen
SVP of Human Resources, Officer
PhaseBio Pharmaceuticals Inc
(PHAS)
0
-100%
11,248
$0.79
$8,885.92
SELL
19 Nov 2021
Burkhardt Glen
VP, Human Resources, Officer
PhaseBio Pharmaceuticals Inc
(PHAS)
0
-100%
5,766
$2.37
$13,665.42
BUY
18 Aug 2021
Hutson Nancy J
Director
PhaseBio Pharmaceuticals Inc
(PHAS)
4,000
+300%
3,000
$3.08
$9,240.00
BUY
18 Aug 2021
Thorp Clay
Director
PhaseBio Pharmaceuticals Inc
(PHAS)
32,943
+43%
10,000
$3.00
$30,000.00
SELL
20 May 2021
Burkhardt Glen
VP, Human Resources, Officer
PhaseBio Pharmaceuticals Inc
(PHAS)
0
-100%
3,811
$3.29
$12,538.19
BUY
3 Dec 2020
HARRIGAN EDMUND
Director
PhaseBio Pharmaceuticals Inc
(PHAS)
6,000
+100%
6,000
$4.12
$24,720.00
BUY
23 Nov 2020
Thorp Clay
Director
PhaseBio Pharmaceuticals Inc
(PHAS)
22,943
+27%
5,000
$3.60
$18,010.00
SELL
20 Nov 2020
Burkhardt Glen
VP, Human Resources, Officer
PhaseBio Pharmaceuticals Inc
(PHAS)
0
-100%
3,497
$3.45
$12,064.65
SELL
1 Jul 2019
Thorp Clay
Director, 10% Owner
PhaseBio Pharmaceuticals Inc
(PHAS)
1,818,638
-0%
2,908
$14.00
$40,712.00
SELL
18 Jun 2019
Thorp Clay
Director, 10% Owner
PhaseBio Pharmaceuticals Inc
(PHAS)
1,820,656
-0%
400
$14.00
$5,600.00
BUY
17 Dec 2018
Hutson Nancy J
Director
PhaseBio Pharmaceuticals Inc
(PHAS)
1,000
+100%
1,000
$4.46
$4,460.00
BUY
13 Dec 2018
Ballance David James
VP, Research and Sci. Affairs, Officer
PhaseBio Pharmaceuticals Inc
(PHAS)
7,600
+15%
1,000
$3.94
$3,940.00
BUY
13 Dec 2018
Mow Jonathan P
Chief Executive Officer, Director, Officer
PhaseBio Pharmaceuticals Inc
(PHAS)
51,199
+1%
1,000
$3.69
$3,690.00
BUY
11 Dec 2018
York Michael
VP, Corporate Development, Officer
PhaseBio Pharmaceuticals Inc
(PHAS)
1,500
+100%
1,500
$3.88
$5,820.00
BUY
7 Dec 2018
Sharp John P
CFO and Secretary, Officer
PhaseBio Pharmaceuticals Inc
(PHAS)
5,000
+100%
5,000
$3.84
$19,200.00
BUY
7 Dec 2018
Mow Jonathan P
Chief Executive Officer, Director, Officer
PhaseBio Pharmaceuticals Inc
(PHAS)
51,699
+6%
3,000
$3.87
$11,616.00
BUY
4 Dec 2018
Thorp Clay
Director, 10% Owner
PhaseBio Pharmaceuticals Inc
(PHAS)
15,799
+33%
4,000
$3.13
$12,520.00
BUY
22 Oct 2018
NEW ENTERPRISE ASSOCIATES 13 LP
10% Owner
PhaseBio Pharmaceuticals Inc
(PHAS)
6,641,634
+37%
1,800,000
$5.00
$9,000,000.00
BUY
22 Oct 2018
ASTRAZENECA PLC
10% Owner
PhaseBio Pharmaceuticals Inc
(PHAS)
3,004,554
+24%
600,000
$5.00
$3,000,000.00
BUY
22 Oct 2018
TUFTS LINDA
Director
PhaseBio Pharmaceuticals Inc
(PHAS)
590,168
+3%
20,000
$5.00
$100,000.00
BUY
22 Oct 2018
Thorp Clay
Director, 10% Owner
PhaseBio Pharmaceuticals Inc
(PHAS)
1,820,933
+19%
300,000
$5.00
$1,500,000.00
BUY
22 Oct 2018
Hatteras Venture Advisors III, LLC
10% Owner
PhaseBio Pharmaceuticals Inc
(PHAS)
1,820,933
+19%
300,000
$5.00
$1,500,000.00
Home